Previous Close | 12.30 |
Open | 12.20 |
Bid | 12.10 x 150000 |
Ask | 12.50 x 150000 |
Day's Range | 12.10 - 12.20 |
52 Week Range | 10.80 - 18.30 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […]
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...
Discover how NeoGenomics is navigating market dynamics with robust revenue growth and strategic expansions in clinical diagnostics.